Get started
CYTODYN INCCYTODYN INCCYTODYN INC

CYTODYN INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

296 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪135.70 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.05EUR
Net income (FY)
‪−74.71 M‬EUR
Revenue (FY)
—
Shares float
‪980.70 M‬
Beta (1Y)
0.61

About CytoDyn Inc.

Sector
Health Technology
CEO
Jacob P. Lalezari
Headquarters
Vancouver
Website
cytodyn.com
Employees (FY)
12
Founded
2002
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 296 is 0.15 EUR — it hasn't changed in the past 24 hours. Watch CYTODYN INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CYTODYN INC stocks are traded under the ticker 296.
CYTODYN INC is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
296 stock is 3.50% volatile and has beta coefficient of 0.61. Track CYTODYN INC stock price on the chart and check out the list of the most volatile stocks — is CYTODYN INC there?
Yes, you can track CYTODYN INC financials in yearly and quarterly reports right on TradingView.
296 stock has risen by 6.47% compared to the previous week, the month change is a 4.52% fall, over the last year CYTODYN INC has showed a 42.64% decrease.
296 net income for the last quarter is ‪−11.03 M‬ EUR, while the quarter before that showed ‪−8.78 M‬ EUR of net income which accounts for −25.59% change. Track more CYTODYN INC financial stats to get the full picture.
Today CYTODYN INC has the market capitalization of ‪135.70 M‬, it has increased by 5.97% over the last week.
No, 296 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 296 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYTODYN INC stock right from TradingView charts — choose your broker and connect to your account.
296 reached its all-time high on Jun 30, 2020 with the price of 8.95 EUR, and its all-time low was 0.12 EUR and was reached on Apr 29, 2024. View more price dynamics on 296 chart.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 12.00 employees. See our rating of the largest employees — is CYTODYN INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYTODYN INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYTODYN INC stock shows the sell signal. See more of CYTODYN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.